Top 8 antiperspirant deodorants for long-lasting freshness: No more sweat, no more worries
An antiperspirant deodorant not only keep sweat away from you, but also keeps you energised and refreshed. With a plethora of antiperspirant deodorants floating in the market, choosing one might be a daunting task. Fret not, as we have listed top 8 antiperspirant deodorants for you to consider this summer.
Dove Men+Care Antiperspirant Deodorant give a powerful sweat protection. It has a formula that's tough on sweat but gentle on skin. With a clean, crisp scent and moisturizing technology, this deodorant keeps you dry for up to 48 hours while also reducing skin irritation. This antiperspirant is ideal for active men who want lasting freshness without compromise, providing all-day confidence.
Dove Men +Care Antiperspirant Deodorant Antiperspirant Sandalwood + Orange Natural Inspired Deodorant Spray 2.6 Oz, Pack Of 1
Arm & Hammer Ultra Max deodorant combines the trusted power of baking soda with advanced antiperspirant protection. Its dual-action formula fights odour and moisture for up to 48 hours, keeping you dry and fresh. This antiperspirant is perfect for anyone seeking dependable performance with a clean, subtle scent. Be it at work or hitting the gym, Ultra Max helps you stay confidently dry.
Arm & Hammer Ultra Max Advanced Anti-Perspirant & Deodorant, Invisible Solid, Unscented, Packaging May Vary, 2.6 oz (73.7 g) (Pack of 6)
A bold man needs a bold antiperspirant. Old Spice Wild Collection's Wolfthorn scent is for the man who lives boldly. Offering invisible, solid protection, it keeps sweat and odour at bay with a wildly addictive citrus and fruit scent. Staying invisible on clothes, this deodorant provides 48-hour protection and a unique aromatic experience.
Old Spice Wild Collection Wolfthorn Scent Mens Invisible Solid Anti-Perspirant & Deodorant 2.6 Oz
Dove Advanced Care Invisible Stick is formulated for both men and women, offering 48-hour sweat and odour protection without staining your clothes. Infused with skin-nourishing ingredients like moisturizers and vitamins, it not only keeps you dry but also cares for your skin. This antiperspirant deo is a smart choice for those who value freshness, comfort, and skin care all in one smooth glide.
Dove Unisex Advanced Care Invisible Stick Antiperspirant Deodorant, Sheer Fresh, 2.6 Oz
Degree Men Dry Spray Antiperspirant offers instant dryness and powerful sweat and odour protection. This antiperspirant has a MotionSense™ technology, that releases a burst of freshness, as per your body motion, when you need it most. This quick-drying formula provides up to 48 hours of protection with no visible residue. So, be it running errands or hitting the gym, Degree's dry spray helps you stay fresh, dry, and confident all day.
Degree Men Dry Spray Antiperspirant, Extreme 3.8 oz
AXE Black Antiperspirant Stick offers a subtle, refined scent with top notes of frozen pear and cedar wood. Designed for men who prefer understated cool, it delivers 48-hour odour and sweat protection in a smooth, non-sticky formula. The sleek black stick goes on invisible and is perfect for daily wear or nights out. Minimalist in style but strong in performance, AXE Black is the go-to for effortless freshness.
AXE 2.7-Ounce , Black Dry Antiperspirant & Deodorant Stick : Antiperspirant Stick for Men, Black, 2.7 Ounce
Rexona MotionSense Invisible Black + White Roll On is specially designed to protect clothes and skin. It provides 48-hour sweat and odour protection while preventing white marks on clothes and yellow stains on whites. With MotionSense™ technology, it keeps up with your every move, releasing bursts of fragrance throughout the day. Ideal for active lifestyles and busy schedules, it's a smart, stylish choice for invisible, dependable protection.
Rexona MotionSense Invisible Black + White 48h Anti-perspirant Roll On for Men, 50ml
Gillette Anti-Perspirant Deodorant offers robust sweat protection with a clean, masculine scent that lasts. Engineered with precision to reduce odour and keep you dry, it's ideal for men who demand high performance and long-lasting results. The formula glides on smoothly and stays invisible, making it perfect for daily use. Whether you're in the office or on the field, Gillette's deodorant keeps you feeling fresh, confident, and ready to take on the day.
Gillette Anti-Perspirant Deodorant Clear Gel Cool Wave, 3.8 oz by Gillette
8 Best deodorant for women you cannot miss to smell great and stay fresh all day long
Davidoff perfumes for him and her: Dive into oceanic freshness with our top 8 picks
Davidoff perfumes for him and her: Dive into oceanic freshness with our top 8 picks
Best body mists to let you keep smelling great for long; Our top 6 picks for you
Antiperspirant deodorant is a product designed to reduce underarm sweat and body odor. It typically contains aluminum-based compounds that temporarily block sweat glands, along with deodorizing agents to neutralize odor.
Regular deodorants only mask or neutralize odor. Antiperspirants go a step further by actually reducing the amount of sweat produced.
Apply to clean, dry underarms. For maximum effectiveness, use at night before bed. This allows the active ingredients time to form a barrier over sweat glands while you're sleeping.
Yes, antiperspirants are safe for daily use. If you have sensitive skin, choose a formula labeled for sensitive skin or consult with a dermatologist.
Yes, the reaction between aluminum compounds and sweat or detergent residues can sometimes cause yellow stains on clothing. Let the product dry completely before dressing to minimize this.
Disclaimer: At Hindustan Times, we help you stay up-to-date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, with respect to the products. The products listed in this article are in no particular order of priority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
UP expands critical care with new ICUs in 40 district hospitals
1 2 Lucknow: The UP govt has set up intensive care units (ICUs) in 40 district hospitals across the state providing much-needed relief to critical patients who otherwise had to travel to metropolitans for treatment. "UP achieved a major milestone by activating Intensive Care Units (ICUs) in 40 district hospitals across the state. The initiative launched 15 months ago significantly improved access to advanced medical treatment for critically ill patients at the local level," an official spokesperson said on Friday. This, the official said, benefitted more than 2,100 patients who received timely, life-saving care in their home districts. "Earlier, many district hospitals had the physical infrastructure for ICUs but lacked the trained personnel to operate them. This led to the frequent referral of critical patients to tertiary hospitals in metropolitan areas. To address this gap, the state govt introduced a comprehensive training programme to build local ICU capabilities," they said. This special initiative, led by Prof Anshul Jain of Maharani Laxmi Bai Medical College, Jhansi—a distinguished expert in critical care—was implemented under the CARE-UP programme. The training covered key areas, including ventilator management, patient monitoring, infection control and other essential components of critical care. It equipped doctors, nurses and lab technicians with the skills necessary to manage and operate ICUs effectively. "Critical care training programme will be conducted regularly to ensure healthcare professionals across the state remain up to date with the latest practices and skills in intensive care," said Prof Jain. "The aim is to make all district hospitals' ICUs fully functional by the end of this year, thereby ensuring comprehensive access to critical care across Uttar Pradesh," he said. Dr Deepak Kumar Maurya, ICU in-charge at Lokbandhu Hospital, said: "Our 11-bed ICU successfully treated over 150 critically ill patients in just the past month." He noted that the trained staff is now adept at operating ventilators and other advanced medical equipment, significantly enhancing the quality of care provided. Echoing these sentiments, Dr Abhishek Singh, ICU in-charge at the Civil Hospital, highlighted how the enhanced training boosted their capacity to handle a greater number of patients. Principal secretary, health and medical education, Parth Sarthi Sen Sharma said: "ICUs are actively functioning in district hospitals enabling patients to access advanced care locally. "
Mint
4 days ago
- Mint
Centre plans easier HIV care at patients' doorsteps, digital data management and patient tracing on the cards
New Delhi: The government plans to take HIV treatment and support to the doorsteps of over 2.5 million living with the virus. The Union health ministry is working on a "person-centered approach" instead of a uniform plan for everyone. This major overhaul, incorporated in the "Operational Guidelines for Care and Support Centres" by the National AIDS Control Organisation (NACO), aims to eradicate AIDS as a public health threat by 2030. According to the 'India HIV Estimation 2023' report, an estimated 2.54 million people were living with HIV in India. The report said that in 2023, approximately 35,870 people in India died due to causes related to AIDS. To be sure, not everyone with HIV develops AIDS, and anti- retroviral or ARV drugs have made living with the disease as manageable as any other condition. Furthermore, the government is looking to roll out new mobile applications such as the NACO-CSC app for tracking and monitoring HIV patients. This initiative aims to digitize data and improve efficiency. A significant change in this new strategy is the widespread adoption of community-based link ART centres (LACs), which will enable HIV patients to pick up their vital antiretroviral (ARV) medicines at local care and support centres, rather than having to travel long distances to bigger hospitals. This "decentralized approach" aims to make treatment much easier to access, especially for those facing travel difficulties, financial strain or other personal challenges. Beyond easier ARV access, the government is also leveraging a major technological leap: digital record-keeping and patient tracking through a new "NACO-CSC mobile application". This initiative will replace the older, time-consuming paper-based system, allowing for real-time updates and seamless coordination between HIV testing centres (ICTC), treatment centres (ARTCs), and the care and support centres (CSCs). This digital shift is expected to save time, speed up patient care, and make the entire process more transparent and efficient. Importantly, patient confidentiality will be strictly maintained as per government data policies. The new treatment guidelines prioritize crucial areas like the Elimination of Vertical Transmission of HIV & Syphilis (EVTHS). This is a vital step to prevent HIV and syphilis from being passed from mothers to their children during pregnancy, childbirth or breastfeeding. This focus is particularly urgent given that an estimated 2,350 new pediatric HIV infections in India in 2023 were due to such vertical transmission. The aim is to ensure that 95% of pregnant and breastfeeding women living with HIV achieve a suppressed viral load, a key factor in preventing transmission to their babies. 'Care and Support Centres (CSCs) will play a crucial role in this by proactively following up with pregnant women living with HIV to ensure they adhere to their treatment, get regular viral load tests, and that their babies receive necessary preventive medicines and early diagnosis," said an official aware of the matter. 'CSCs will help bridge the gaps in linking newly diagnosed individuals to treatment, improve how well patients stick to their medicine plans, and track those who might interrupt treatment or have a high viral load. CSCs also play a critical role in connecting patients to various social welfare schemes and actively work to reduce the stigma and discrimination that people living with HIV often face," the official added. Another focus of the new protocol is the comprehensive management of HIV-related co-morbidities and advanced HIV disease. This means addressing other health conditions that people living with HIV might develop, ensuring they receive holistic care. Indian pharmaceutical companies, including Cipla, Aurobindo Pharma, Zydus Lifesciences and Lupin, are key manufacturers of ARV drugs essential for HIV treatment. The market for HIV drugs is substantial, estimated at $250.23 million in 2022, with projections to grow to $389.90 million by 2030. Queries sent to the above mentioned companies remained unanswered. Raman Gangakhedkar, distinguished professor, Symbiosis International University, Pune and former C.G. Pandit national chair at the Indian Council on Medical Research (ICMR),said that though the National AIDS Control Programme continues to be one of the most successful nationally and internationally, it faces the challenge of linking 95% of HIV infected Individuals to ART services and ensure lifelong treatment adherence for the 2030 elimination goal. 'Vast number of People Living with HIV (PLHIV) cannot be followed up for the treatment and get missed, migration, opt out for treatment from closest clinics and social stigma are some of the key challenges for linkage as well continuation of antiretroviral therapy that has ensured that one can live as long as others who are not infected. Tracking individuals detected to be infected from detection to maintenance of suppressed viral load is critical," Dr. Gangakhedkar said. He said that to combat this, community involvement is paramount in the fight to eliminate HIV. 'The government now plans to establish more Care and Support Centres across the country in most of the districts and will not only track the person to ensure quality treatment against HIV disease but also monitor TB and other non-communicable diseases as a component of comprehensive care. The current guidelines cover objective parameters to be an agency to implement CSC related services, parameters used for rigorous monitoring and evaluation based on their performance. The HIV infected individuals will soon be able to get their medicines and refills directly from these local CSCs, eliminating the need to travel long distances to ART centres and when they are unable to travel due to sickness. The CSC will also counsel them comprehensively and also ensure measures related social stigma are handled well." He said that some of the patients on ART may prefer private healthcare to begin with and also during treatment from ART Centres. In such circumstances, the government often lacks crucial data on whether they're actually receiving treatment. 'To address this, all newly diagnosed HIV-positive individuals will now be linked to an ART centre. Furthermore, a digital mobile application will be instrumental in tracing patients anywhere in the country. Our major goal is to monitor active HIV cases and their treatment in India," said Dr. Gangakhedkar.
Time of India
4 days ago
- Time of India
‘One in three person with diabetes develops chronic kidney disease'
1 2 Lucknow: One in three people with diabetes eventually develop chronic kidney disease, which may lead to renal failure and cardiovascular complications, suggests a study undertaken by doctors at SGPGI. Sharing details, head of molecular medicine and biotechnology, Prof Swasti Tiwari said: "Conducted at the ICMR Centre of Advanced Research and Excellence (CARE) in our department, the study concluded that early detection of CKD could ensure timely therapy and management. The study also identified biomarkers with the potential for the early diagnosis of kidney disease in patients with diabetes." Adding that the biomarkers are unique in that they have the potential to predict CKD before its onset, she further said: "These biomarkers are found inside nanosized vesicles (thousands of times smaller than a hair) in human urine, making their diagnosis non-invasive. The studies were initiated in 2019, in which around 1,000 diabetic patients were recruited from the communities at Lucknow and Puducherry. Patients were followed up for about five years. " She said a patent was filed for the same in March 2024. "The ICMR included this innovation in their annual report for 2023-24. It is noteworthy that the laboratory in the department of molecular medicine & biotechnology at SGPGI was the first in India to demonstrate the usefulness of urine exosomes in kidney disease," she said. The department also took the initiative for capacity building within the country for early disease diagnosis. Accordingly, two national capacity-building workshops were organised to impart technological skills generated through the CARE project. The team included Dr Dharmendra K Chaudhary, Dr Sukhanshi Khandpal, Dr Deendayal Mishra, and Dr Biswajeet Sahoo from SGPGI, in addition to project staff members from the Community Medicine Department, PMIS, Puducherry.
